In vivo response of the human epigenome to vitamin D 2
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A C C E P T E D M
A N U S C R I P T blood mononuclear cells without any further in vitro culture and at all nine time points epigenome-wide chromatin accessibility was assessed by applying FAIRE-seq (formaldehyde-assisted isolation of regulatory elements sequencing). The vitamin D3 bolus resulted in an average raise in 25-hydroxyvitamin D3 (25(OH)D3) serum concentration of 11.9 and 19.4 nM within one and two days, respectively. Consistently accessible chromatin was detected at 5,205 genomic loci, the 853 most prominent of which a self-organizing map algorithm classified into early, delayed and non-responding genomic regions: 70 loci showed already after one day and 361 sites after two days significant (p < 0.0001) chromatin opening or closing. Interestingly, more than half of these genomic regions overlap with transcription start sites, but the change of chromatin accessibility at these sites has no direct effect on the transcriptome. Some of the vitamin D responsive chromatin sites cluster at specific loci within the human genome, the most prominent of which is the human leukocyte antigen region in chromosome 6. In conclusion, this study demonstrates that under in vivo conditions A C C E P T E D M A N U S C R I P T 3 a rather minor rise in 25(OH)D3 serum levels is sufficient to result in significant changes at hundreds of sites within the epigenome of human leukocytes.
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A N U S C R I P T 
Vitamin D3 is a pre-hormone that has via its metabolite 1α,25-dihydroxyvitamin D3
(1,25(OH)2D3), which is binding with high affinity to the transcription factor vitamin D receptor (VDR), direct effects on gene expression in most human tissues and cell types [1, 2] .
The natural way of producing vitamin D3 is its synthesis from 7-dehydrocholesterol in UV-B exposed skin [3] , but because of the increased indoor activities, skin protection by clothing or sunscreen use or life at latitudes above 40°, most individuals have to take up the molecule via diet or direct supplementation with pills [4] .
Serum 25(OH)D3 concentrations serve as a biomarker of the vitamin D status [5] and a level below 50 nM (20 ng/ml) is defined as vitamin D insufficiency [6] . Vitamin D has a number of physiological functions, such as maintaining the balance of calcium and phosphorus homeostasis, controlling innate and adaptive immunity and modulating cellular growth [7] [8] [9] .
A low vitamin D status can have musculoskeletal consequences, such as rickets in children and osteomalacia and fractures in adults [10] . Moreover, vitamin D insufficiency is linked to multiple sclerosis, type 2 diabetes, cardiovascular disease and cancers of the breast, prostate and colon [11] [12] [13] [14] [15] .
Chromatin is a complex of nucleosomes around which genomic DNA is wrapped [16] . The default state of chromatin is densely packed heterochromatin that protects genes from uncontrolled activation [17] . Thus, chromatin is only accessible at selected regions, such as enhancers and transcription start sites (TSSs) of those genes that need to be expressed in a given tissue or cell type [18] . Accessible chromatin loci can be detected genome-wide by the method FAIRE-seq [19] . For example, in THP-1 human monocytes 1,25(OH)2D3 changes significantly (p < 0.05) chromatin accessibility at nearly 9,000 genomic loci [20] . Maximal chromatin opening was observed after 24 h, while after 48 h most sites are again closed. This indicates that the primary effect of activating VDR by 1,25(OH)2D3 is a transient opening or
closing of chromatin at specific enhancer and TSS regions, which eventually results in activation or repression of vitamin D target genes [21] . There are a few hundred primary target genes of VDR and 1,25(OH)2D3 [2] , i.e. these genes change their expression already
within a few hours after VDR activation. However, for a most comprehensive insight on the physiological actions of vitamin D also long-term, secondary effects on gene expression in the time frame of 1-2 days have to be taken into account.
In order to study vitamin D-dependent gene regulation under in vivo conditions in human, we designed the VitDbol vitamin D intervention trial (NCT02063334, ClinicalTrials.gov). In phase I of the study, 35 healthy young adults were exposed once to a vitamin D3 bolus (2,000 µg) and the change of chromatin accessibility at selected genomic regions [22] and the induction of a few primary vitamin D target genes [23] was measured from peripheral blood mononuclear cells (PBMCs) at days 0, 1 and 2. This demonstrated that a single vitamin D3 bolus is sufficient to activate genes. This result is in line with the study of Hossein-nezhad et al. [24] , which indicated that two months of daily vitamin D3 supplementation with either 10 or 50 µg resulted in the significant (p < 0.01) regulation of 291 genes in PBMCs of in total eight study participants. Similarly, a weekly supplementation of 47 subjects with 500 µg vitamin D3 over 3-5 years resulted in the significant (p < 0.05) regulation of 99 genes in whole blood compared to 47 placebo treated individuals [25] .
In the study presented here, we show results from phase II of VitDbol, in which one individual was exposed three times in a row every 28 days with a vitamin D3 bolus.
Epigenome-wide chromatin accessibility within PBMCs was measured at days 0, 1 and 2. concentrations were measured using a high performance liquid chromatography/coulometric electrode array as described previously [26] .
MATERIAL AND METHODS

Sample collection
A C C E P T E D M A N U S C R I P T
FAIRE-seq and its analysis
PBMCs were isolated within one hour after blood draw from 8 ml of peripheral blood in a
Vacutainer CPT Cell Preparation Tube with sodium citrate (Becton Dickinson) according to the manufacturer's instructions. FAIRE was performed according to the protocol published by
Giresi et al. [27] with some modifications [20] . In short, 7. Purified genomic DNA samples were sequenced at 50 bp read length using standard manufacturer protocols at the Gene Core at the EMBL (Heidelberg, Germany). For FAIRE-
seq data analysis statistically significant peaks were identified using the Zinba program package version 2.02 by setting the mean fragment length at 200 bp and using other settings as recommended for FAIRE-seq in the Zinba website (http://code.google.com/p/zinba/wiki/UsingZINBA) including peak refinement [28] . In order to enable comparisons across all nine time points, common peak borders were identified by detecting the local maxima of original peak border density and filtering out all resulting intervals that were > 2 kb. The peak statistics (except the false discovery rate (FDR)) were recalculated as done in MACS2 version 2.0.9 and all intervals, where the maximal fold enrichment (FE) over the entire data set was < 3, were filtered out. FAIRE-seq raw data are available at Gene Expression Omnibus (GEO; www.ncbi.nlm.nih.gov/geo) at GSE106162.
Functional characterization of FAIRE peak loci
5,205 FAIRE-seq peaks were identified at all nine time points (Table S1 ). In order to obtain higher accuracy in data integration, persistent peaks fulfilling more stringent conditions were selected by the threshold of a likelihood function, which takes into account i) a p-value < 0.05, ii) the FE with respect to input, iii) the number of sequencing reads and iv) the shape of the peak: 1 -k x 1/normalized FE -r/R, where k and r are normalization factors, and R is the proportion of reads that are piled up very close to the peak's summit giving the peak the shape of a rectangle as opposed to the expected Gaussian or Poisson-like shape. The
Integrative Genomics Viewer [29] was used to visualize FAIRE-seq data at example genomic regions.
For a better characterization of the dynamics of the resulting 853 FAIRE peaks, selforganizing maps (SOM) were applied. SOM [30] is an unsupervised method that allows the identification of representative profiles of the inspected high-dimensional data. The method was performed with the peak FE at all nine time points, i.e. the SOM vector represented a nine-dimensional input space. SOM segregated the 853 most prominent FAIRE peaks into one of nine possible classes in a 3x3 lattice. This allows a visual inspection of the similarities
of chromatin accessibility as a function of time and provides grounds for more elaborated statistical interrogations.
The nine SOM classes differed along several lines. Firstly, the number of peaks in each SOM class was not homogeneous, varying from 13 to 360. This large variation is a sign of nonrandomness in the data, since the clustering of a random collection of peaks would have produced groups of similar size. Secondly, the profiles were different not only in terms of the peak FE, but also in terms of the dynamics along the nine measured days, which is shown as the different shapes depicted by the bars in the SOM classes. Finally, while some of the profiles of the SOM classes showed a cyclic behavior with clear statistical differences compared to the chromatin state at day 0, others could be described by a less variable profile as a function of time.
Statistics
The segregation of the 853 most prominent accessible chromatin regions into nine different classes allowed hypothesis testing. In order to test for significant changes between day 0 and the subsequent days for a given profile, a Wilcoxon-Mann-Whitney test (U-test) was applied.
The test is less restricted than the Student's T-test, since among other features, it allows data to be described by any distribution, thus being non-parametric. To test for statistical differences between a given day and day 0, a U-test was applied for the peak FE at a given day and the FE at day 0 for all peaks in the class. Once the U-test and its corresponding pvalue were obtained, the ratio between the peak FE at the given day and the peak FE at the corresponding day 0 for all peaks in the class was calculated. If the average of this ratio was higher than 1.5 and the p-value < 0.01, a statistically significant difference was declared.
RESULTS
VitDbol phase II study
The focus of phase II of the vitamin D intervention study VitDbol was the genome-wide analysis of RNA and chromatin samples that were obtained from PBMCs of healthy adults one or two days after they had been exposed to a vitamin D3 bolus (2,000 µg once). An essential part of phase II is the here presented proof-of-principle study, in which in a consecutive experiment one individual was exposed at days 0, 28 and 56 with a vitamin D3
bolus. PBMCs were isolated immediately after blood samples were drawn at days 0, 1, 2, 28, 29, 30, 56, 57 and 58. 25(OH)D3 serum levels increased on average by 11.9 ± 2.8 nM after one day and 19.4 ± 5.4 nM after two days of vitamin D3 bolus supplementation (Fig. 1) .
These rises were slightly lower than the averages of 17.4 and 21.1 nM that were determined after one and two days, respectively, for the 27 vitamin D3 bolus supplemented participants of phase I of VitDbol (the 8 remaining participants of VitDbol received placebo) [22] .
In vivo responsiveness of the human epigenome to vitamin D
FAIRE-seq analysis was performed with chromatin samples that were isolated from PBMCs obtained from the triplicate vitamin D3 bolus supplementation experiment (Fig. 1) . In total 5,205 genomic regions showed at all nine time points a significant (FDR > 0.05) FE in reference to input reference, i.e. these sites showed consistently accessible chromatin throughout the whole in vivo experiment (Table S1) . A peak likelihood value of more than 0.7 turned out to be a meaningful threshold, since at this value a prominent change in the proportion of affected sites was observed (Fig. S1) . The proportion of peaks is described by an exponential decrease for likelihoods lower than 0.7, but at that value, an abrupt change occurs, giving indication that above this specific point, the nature of the peaks is different to that of the peaks in the previous range. This led to a list of 853 most prominent sites of accessible chromatin in PBMCs (Table S1 ). Then SOM with a 3x3 lattice was applied, in order to segregate the 853 genomic regions into nine classes of most similar properties
concerning their chromatin accessibility over time (Fig. 2) . The significance of the change in chromatin accessibility was determined for the average of the members of each SOM class at each time point in relation to the respective status at day 0.
In almost all classes, it was observed an increase in the subsequent days after the bolus ingestion. However, the statistically significant effects are less common. The 14 members of SOM class 1 showed a significant change exclusively at day 29, i.e. at day 1 of the second intervention series, while the 56 members of class 3 reproducibly displayed increased chromatin accessibility at days 1, 29 and 57, i.e. at the first day of each of the three series (Fig. 2) . We interpret the 70 genomic regions in classes 1 and 3 as early responding regions of the human epigenome to vitamin D stimulation. In contrast, the 13, 39 and 83 members of Interestingly, we observed in none of the nine SOM classes a significant difference in the chromatin accessibility when comparing day 0 with days 28 and 56. This means that even at the early and delayed responsive regions the chromatin status had returned within 28 days back to their ground state, i.e. the chromatin opening effects of the vitamin D3 bolus on the human epigenome were primarily transient.
TSS overlap of accessible chromatin regions
From the complete set of 5,205 consistently accessible genomic sites 1,688 (32.4%) overlapped with a TSS region ( Table S1 ). This rate significantly increased to 58.7% (502 of (Fig. 3A) , close to the TSS of the SUN1 (Sad1 and UNC84 domain containing 1) gene (Fig. 3B) and on the TSS of the WRAP73 (WD repeat containing, antisense to TP73) gene (Fig. 3C) . In contrast, examples of the delayed responding chromatin loci were those on the TSS regions of the genes MAPK8 (mitogen-activated protein kinase 8, 
Genome-wide distribution of vitamin D responsive chromatin regions
The genome-wide display of the average FE of the 853 most prominent sites of chromatin accessibility over the nine time points of the triplicate vitamin D3 bolus experiment visualized that the 70 early vitamin D responsive regions were on average more prominent than the delayed responsive loci (Fig. 4) . The latter sites showed in turn a higher average FE than the non-responsive regions. In particular, when normalized by TSS density, which is highest at chromosome 19, there was no striking clustering of the sites of chromatin accessibility.
Nevertheless, the genomic region around the human leukocyte antigen (HLA) cluster in chromosome 6 showed the highest normalized density of accessible chromatin. This region
contains not only the genes for the different subtypes of the major histocompatibility complex (MHC), but also those for key cytokines, such as TNF (tumor necrosis factor), and other important signaling molecules, such as the lysine methyltransferase EHMT2 (euchromatic histone lysine methyltransferase 2). For example, a 1 Mb sub-region of the HLA cluster contains six prominent sites of chromatin accessibility, three of which were significantly vitamin D responsive (Fig. 5) .
DISCUSSION
This study refers to phase II of the VitDbol vitamin D3 intervention trial. In a proof-ofprinciple it demonstrates that a vitamin D3 bolus can reproducibly induce significant of the latter pointed to a vitamin D target gene [20] . This suggests that more complex gene regulatory scenarios apply, such as vitamin D responsiveness of topologically associated domains [20, 31, 36] . So far it can only be concluded that the vitamin D response of chromatin accessibility represents a kind of memory function of the epigenome that needs further investigations.
Basically all cellular components of PBMCs belong to the innate and adaptive immune system. Therefore, it is not surprising that the immunologically most important region of the human genome, the HLA cluster, also highlights as a "hotspot" in the epigenome of PBMCs.
However, it is remarkable that the HLA cluster is also a focused region of the vitamin D responsiveness of the epigenome. This observation provides a strong link to the impact of vitamin D on the control of the immune system [37] .
In conclusion, in this proof-of-principle study we demonstrated that under in vivo conditions a rather minor rise in 25(OH)D3 serum levels results in significant changes at hundreds of sites within the epigenome of human leukocytes.
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